Espada, Luis C.
HRN: 22-75-62 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/19/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/19/2023
03/19/2023
IV
4.5 Grams
Ld
Cap Mr
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes